Emami will hold a meeting of the Board of Directors of the Company on 1 August 2024.Powered by Capital Market - Live News

Net profit of Emami rose 3.09% to Rs 148.90 crore in the quarter ended March 2024 as against Rs 144.43 crore during the previous quarter ended March 2023. Sales rose 6.61% to Rs 891.24 crore in the quarter ended March 2024 as against Rs 835.95 crore during the previous quarter ended March 2023.For the full year,net profit rose 13.13% to Rs 723.53 crore in the year ended March 2024 as against Rs 639.57 crore during the previous year ended March 2023. Sales rose 5.06% to Rs 3578.09 crore in the year ended March 2024 as against Rs 3405.73 crore during the previous year ended March 2023. ParticularsQuarter EndedYear Ended�Mar. 2024Mar. 2023% Var.Mar. 2024Mar. 2023% Var. Sales891.24835.95 7 3578.093405.73 5 OPM %23.5023.86 -26.4325.11 - PBDT217.23211.84 3 982.63916.80 7 PBT169.23147.87 14 796.73669.55 19 NP148.90144.43 3 723.53639.57 13 Powered by Capital Market - Live News

Emami will hold a meeting of the Board of Directors of the Company on 29 May 2024.Powered by Capital Market - Live News

Emami holds 95.36% in the paid up capital of its subsidiary Company, Brillare Science (Brillare). The Company has further entered into Share Purchase Agreement with the founder & other shareholders of Brillare for acquiring remaining stake of 4.64 % of that Company. Consequently, Emami`s Shareholding in Brillare has increased from 95.36% to 100% and it has become a wholly owned subsidiary of the Company. Powered by Capital Market - Live News

Emami announced that the Board of Directors of the Company at its meeting held on 9 February 2024, has recommended a Second Interim dividend of Rs.4 per share (i.e.400%), subject to the approval of the shareholders.Powered by Capital Market - Live News